VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,000,089 | -23.2% | 1,387,416 | +101.2% | 0.00% | -50.0% |
| Q2 2023 | $16,918,980 | +21.4% | 689,726 | +15.2% | 0.00% | +100.0% |
| Q1 2023 | $13,935,426 | -53.3% | 598,858 | -49.2% | 0.00% | -66.7% |
| Q4 2022 | $29,810,825 | +35.0% | 1,177,828 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $22,088,000 | -19.8% | 1,145,658 | +5.9% | 0.00% | -25.0% |
| Q2 2022 | $27,544,000 | +81.0% | 1,081,374 | +82.8% | 0.00% | +100.0% |
| Q1 2022 | $15,218,000 | -70.5% | 591,678 | -51.9% | 0.00% | -66.7% |
| Q4 2021 | $51,546,000 | +719.4% | 1,231,094 | +751.6% | 0.01% | +500.0% |
| Q3 2021 | $6,291,000 | -60.8% | 144,570 | -57.4% | 0.00% | -50.0% |
| Q2 2021 | $16,038,000 | -22.3% | 339,217 | -15.8% | 0.00% | -33.3% |
| Q1 2021 | $20,643,000 | +717.2% | 402,641 | +326.8% | 0.00% | – |
| Q4 2020 | $2,526,000 | +80.3% | 94,334 | +131.2% | 0.00% | – |
| Q3 2020 | $1,401,000 | +20.2% | 40,809 | +43.4% | 0.00% | – |
| Q2 2020 | $1,166,000 | +85.1% | 28,459 | +54.8% | 0.00% | – |
| Q1 2020 | $630,000 | +223.1% | 18,386 | +19.0% | 0.00% | – |
| Q4 2019 | $195,000 | – | 15,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |